We use cookies on this site to enable your digital experience. By continuing to use this site, you are agreeing to our cookie policy. close

Ranbaxy Launches Generic Clarithromycin After Defeating Abbott In U.K. Court

Law360 (December 1, 2004, 12:00 AM EST) -- Indian drug maker Ranbaxy Laboratories Ltd. has a launched a generic version of the anti-infective drug clarithromycin in the U.K. after winning a patent infringement lawsuit brought by U.S.-based Abbott Laboratories....
To view the full article, register now.
Law360 Pro Say Podcast
Check out Law360's new podcast, Pro Say, which offers a weekly recap of both the biggest stories and hidden gems from the world of law.